ONCO Share Price Performance
CA$1.70
1.05 (161.54%)
Price CA$1.70
Share Pricen/a
Onco-Innovations Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
ONCO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Onco-Innovations Limited Key Details
Last Reported Earnings
Jul 31, 2025
Next Reporting Earnings
n/a
- -0.19
- 100.00%
- -12,771.92%
- 0%
About ONCO
- Founded
- n/a
- Employees
- 1
- CEO
- WebsiteView website
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. Onco-Innovations Limited is headquartered in Calgary, Canada.
